Mohan Jitendra - 07 May 2026 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
11 May 2026, 20:15:13 UTC
Prior SEC filing
21 Apr 2026
Next SEC filing
20 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Philip Mazzara, Attorney-in-Fact

Key filing fact

Mohan Jitendra filed Form 4 for Astera Labs, Inc. (ALAB) on 11 May 2026.

Key facts

  • This page summarizes Mohan Jitendra's Form 4 filing for Astera Labs, Inc. (ALAB).
  • 7 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 11 May 2026, 20:15.

Change

  • Previous filing in this sequence was filed on 21 Apr 2026.
  • Current net transaction value: -$28,013,250.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001998053 Primary reporting owner

Mohan Jitendra

Relationship
Chief Executive Officer, Director
Address
C/O ASTERA LABS, INC., 2345 NORTH FIRST STREET, SAN JOSE
Signature
/s/ Philip Mazzara, Attorney-in-Fact
Signature date
11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALAB transaction

Common Stock

Sale

Transaction value
$15,821,971
Shares
-79,377
Change %
-2%
Price
$199.33
Shares after
3,989,757
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F2, F3
ALAB transaction

Common Stock

Sale

Transaction value
$6,864,787
Shares
-34,234
Change %
-0.86%
Price
$200.53
Shares after
3,955,523
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F4
ALAB transaction

Common Stock

Sale

Transaction value
$2,995,798
Shares
-14,875
Change %
-0.38%
Price
$201.40
Shares after
3,940,648
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F5
ALAB transaction

Common Stock

Sale

Transaction value
$1,224,756
Shares
-6,048
Change %
-0.15%
Price
$202.51
Shares after
3,934,600
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F6
ALAB transaction

Common Stock

Sale

Transaction value
$640,047
Shares
-3,146
Change %
-0.08%
Price
$203.45
Shares after
3,931,454
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F7
ALAB transaction

Common Stock

Sale

Transaction value
$268,384
Shares
-1,311
Change %
-0.03%
Price
$204.72
Shares after
3,930,143
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F8
ALAB transaction

Common Stock

Sale

Transaction value
$197,507
Shares
-960
Change %
-0.02%
Price
$205.74
Shares after
3,929,183
Date
07 May 2026
Ownership
By Living Trust
Footnotes
F1, F3, F9
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
699,999
Date
07 May 2026
Ownership
By Trust
Footnotes
F10
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
07 May 2026
Ownership
By 2021 Trust 1
Footnotes
F11
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
700,000
Date
07 May 2026
Ownership
By 2021 Trust 2
Footnotes
F12
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
07 May 2026
Ownership
By 2022 Trust 1
Footnotes
F13
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
450,001
Date
07 May 2026
Ownership
By 2022 Trust 2
Footnotes
F14
ALAB holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,452,739
Date
07 May 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 14 footnotes

Footnote F1

The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.

Footnote F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.0000 to $199.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

These shares are owned directly by a living trust (the "Living Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.0000 to $200.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.0000 to $201.9900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.1000 to $203.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.1800 to $204.1200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.3900 to $205.3450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.3900 to $205.9700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F10

These shares are owned directly by an estate planning trust (the "Trust"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F11

These shares are owned directly by an estate planning trust (the "2021 Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F12

These shares are owned directly by an estate planning trust (the "2021 Trust 2"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F13

These shares are owned directly by an estate planning trust (the "2022 Trust 1"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F14

These shares are owned directly by an estate planning trust (the "2022 Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .